ASCP BOC Qualification in Apheresis (QIA) Examination Practice Test
Apheresis practice brings together extracorporeal blood processing, component separation, and therapeutic removal or collection of selected blood constituents. The available questions sample concepts such as centrifugal separation, vascular access considerations, plasma exchange, donor medication history, and monitoring for acute reactions during a procedure.
Exam overview
About the ASCP BOC Qualification in Apheresis (QIA) Examination Exam
Apheresis professionals must connect the purpose of a procedure with the component being collected or removed, the patient's clinical status, and the equipment process. Relevant decisions include assessing access-related risk, considering fibrinogen when planning plasma exchange, and recognizing how removal of plasma can reduce a circulating pathogenic substance. Collection work also depends on evaluating factors that may affect product function, such as recent aspirin use before platelet collection. During treatment, operators need to notice signs of complications, respond promptly to changes such as dyspnea or facial swelling, and communicate medication changes that may affect hemodynamic stability. Accurate records of procedure times, processed volume, complications, and product identifiers support continuity of care and traceability through processing and disposition.
Sample Practice Questions
Review a selection from this exam's published US Practice Tests practice bank.
A therapeutic apheresis procedure is ordered for a patient whose platelet count is very low. Which concern should be considered before placing or manipulating vascular access?
Show answer
Correct answer: AThrombocytopenia can increase bleeding risk, including at puncture sites. Access planning and hemostasis should account for the patient's platelet status and clinical circumstances.
When preparing a therapeutic plasma exchange, why may the patient's fibrinogen level be relevant to treatment planning?
Show answer
Correct answer: AFibrinogen is a plasma coagulation protein and may decrease when plasma is removed. Its level can inform assessment of coagulation status and bleeding risk, especially when repeated exchanges or invasive procedures are involved.
During extracorporeal blood processing, a patient reports sudden shortness of breath and develops facial swelling. What should the operator do first?
Show answer
Correct answer: ASudden respiratory symptoms with facial swelling may indicate a serious acute reaction. The procedure should be stopped or paused as appropriate, and urgent clinical assessment and emergency response should be initiated without delay.
In centrifugal apheresis, what primarily allows blood components to be separated into layers?
Show answer
Correct answer: ACentrifugal separation uses differences in the density of blood components so that they form layers under centrifugal force. The device can then direct selected components to collection or return pathways.
A platelet collection is being planned for a donor with a recent history of taking aspirin. Why is this medication history relevant?
Show answer
Correct answer: AAspirin inhibits platelet function, so recent use may affect the suitability or intended use of a platelet component. The collection service should apply its established medication-history criteria and product requirements.
What is the main purpose of documenting the start and stop times, processed volume, and any complications of an apheresis procedure?
Show answer
Correct answer: AAccurate procedure documentation supports traceability, communication among care teams, assessment of the procedure, and investigation of any adverse event or deviation. It complements, rather than replaces, equipment checks and product labeling.
For a collected cellular therapy product, why is a unique product identifier maintained from collection through processing and disposition?
Show answer
Correct answer: AUnique identification and traceability link the product to the correct collection and subsequent processing steps. They are essential safeguards against product mix-ups and support investigation and disposition when needed.
How to use this practice test
The free QIA practice bank contains 50 questions; each session presents up to 20 selected at random. Complete a session to see your results and identify concepts to revisit, such as procedure planning, component separation, donor assessment, reaction response, and product documentation.
Preparation tips
- Compare therapeutic plasma exchange with procedures that target a specific circulating constituent, and explain what is removed in each case.
- Review how centrifugal force separates blood components into layers and how that principle supports collection or therapeutic procedures.
- Practice assessing procedural risks from vascular access, low platelet counts, fibrinogen results, and medications that may affect collected platelet function or patient blood pressure.
- For acute symptoms during extracorporeal processing, work through recognition, immediate response, and escalation steps using the applicable facility procedure.
- Trace a cellular therapy product from collection through processing and disposition, noting where unique identification and procedure documentation preserve traceability.